Light-Based Monitoring (SR-NIRS) for Suspected Testicular Torsion in Children
SR-NIRS
Feasibility and Exploratory Evaluation of Spatially-resolved Near-infrared Spectroscopy (SR-NIRS) in Testicular Torsion
1 other identifier
interventional
74
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether a non-invasive light-based test called Spatially Resolved Near-Infrared Spectroscopy (SR-NIRS) can measure blood flow and oxygen levels in the testicles of children. The study includes boys aged 1 month to 18 years, including those without testicular problems (part 1) and those with sudden scrotal pain (part 2). Testicular torsion is a condition where the blood supply to the testicle becomes twisted and reduced. This can lead to permanent damage if not treated quickly. Current methods, such as ultrasound or surgery, may not always be immediately available and can sometimes lead to delays or unnecessary procedures. This study explores whether SR-NIRS can provide useful information about blood flow and oxygen levels in painful testicles of the children. The main questions the study aims to answer are:
- Part 1 (Feasibility study, n=24) Can SR-NIRS reliably collect usable measurements in healthy children?
- Part 2 (exploratory study, n=50): Do SR-NIRS measurements differ between children with and without torsion? Participants will:
- Have a small probe placed on the skin over the testicle(s) and thigh
- Undergo a brief measurement during a single visit This study will not affect diagnosis or treatment. The results will help guide future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2026
CompletedFirst Posted
Study publicly available on registry
April 23, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
Study Completion
Last participant's last visit for all outcomes
September 1, 2029
April 23, 2026
April 1, 2026
3 years
March 31, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Part 1- Feasibility of the investigational SR-NIRS device for successful acquisition of interpretable tissue oxygenation and perfusion signals from pediatric testicular tissue in children with clinically unaffected testes.
Percentage of participants with at least 30 seconds of interpretable, artifact-free SR-NIRS recordings obtained at both measurement sites (testis and ipsilateral thigh reference site)
Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).
Part 2- Difference in Regional Tissue Perfusion Index (RTPI) between torsion and non-torsion presentations in children with acute scrotum
Participant-level standardized RTPI, defined as: \[RTPI in affected testicle -RTPI in unaffected testicle/ RTPI in unaffected testicle\] x100 will be compared between torsion and non-torsion groups.
Day1; The outcome is measured immediately after the completion of the NIRS test (intervention)
Secondary Outcomes (4)
Part 2- Difference in TOI between torsion and non-torsion presentation in children with acute scrotum.
Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).
Part 1- Reference ranges for SR-NIRS-derived parameters (HbO₂, HHb, THb, TOI, RTPI) in children with unaffected testis.
Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).
Part 2-Differences in SR-NIRS tissue oxygenation parameters (Oxygenated hemoglobin (O₂Hb), Deoxygenated hemoglobin (HHb), Total hemoglobin (THb)) between children with and without torsion.
Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).
Part 1 and Part 2-Safety and tolerability of SR-NIRS measurements
Day1; The outcome is measured immediately after the completion of the NIRS test (the intervention).
Study Arms (2)
Healthy Controls
EXPERIMENTALPart 1 study, SR-NIRS signal acquisition from testis and ipsilateral upper thigh, each for one minute
Testicular Torsion Cases
EXPERIMENTALPart 2 study, SR-NIRS signal recording of at least one minute from affected testis, contralateral testis, and upper thigh.
Interventions
Eligibility Criteria
You may qualify if:
- Part 1:
- Boys aged 1 month to 18 years.
- Presenting to the urology clinic with non-testicular complaints.
- Part 2:
- Boys aged 1 month to 18 years.
- Presenting to the Emergency Room or urology clinic with acute scrotum, defined as a TWIST (Testicular Workup for Ischemia and Suspected Torsion) score ≥ 1.
You may not qualify if:
- Part 1:
- Any scrotal or testicular pathology, including hydrocele, inguinal hernia, undescended testicle, varicocele, or scrotal pain.
- History of testicular or scrotal surgery, except unilateral orchiopexy. Unable or unwilling to provide consent/assent
- Part 2:
- Boys with a history of testicular surgery, scrotal surgery, inguinal hernia, hydrocele, varicocele, or undescended testicle.
- Unable or unwilling to provide consent/assent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kourosh Afsharlead
Study Sites (1)
BC Children's Hospital
Vancouver, British Columbia, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kourosh Afshar, MD, FRCSC
University of British Columbia, Department of Urologic Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The person interpreting SR-NIRS signals is blind to the final diagnosis of the participants in part 2 (testicular torsion vs other).
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Urologic Sciences, Faculty of Medicine, University of British Columbia
Study Record Dates
First Submitted
March 31, 2026
First Posted
April 23, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2029
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share